Share on StockTwits

CONMED (NASDAQ:CNMD) EVP William Abraham sold 7,423 shares of CONMED stock on the open market in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $38.36, for a total value of $284,746.28. Following the sale, the executive vice president now directly owns 1,486 shares in the company, valued at approximately $57,003. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

CONMED (NASDAQ:CNMD) traded down 0.15% on Thursday, hitting $39.14. 158,111 shares of the company’s stock traded hands. CONMED has a one year low of $30.86 and a one year high of $50.47. The stock has a 50-day moving average of $39.49 and a 200-day moving average of $43.90. The company has a market cap of $1.070 billion and a P/E ratio of 31.39.

CONMED (NASDAQ:CNMD) last released its earnings data on Wednesday, July 23rd. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.47. The company had revenue of $188.20 million for the quarter, compared to the consensus estimate of $190.62 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was down 2.5% on a year-over-year basis. Analysts expect that CONMED will post $1.87 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Monday, October 6th. Investors of record on Monday, September 15th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.04%. The ex-dividend date is Thursday, September 11th.

Separately, analysts at Zacks reiterated a “neutral” rating on shares of CONMED in a research note on Friday, July 18th. They now have a $44.00 price target on the stock.

CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.

Receive News & Ratings for CONMED Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Co and related companies with Analyst Ratings Network's FREE daily email newsletter.